Board of Directors

Igal Ladabaum

Igal Ladabaum is a co-founder, a director, and the Chief Executive Officer of Hospi Corporation. Igal is an experienced medical device executive and an engineer with over 28 issued patents.

Igal also serves as Chairman of the Board of Attune Medical, a company that develops and markets devices to control patient temperature, including for esophageal protection during cardiac ablation procedures.

Prior to co-founding Hospi, Igal led the engineering and clinical research team that brought the Lyric hearing aid to market. Lyric’s success resulted in the acquisition of InSound Medical by Sonova. Prior to his work at InSound, Igal Ladabaum was the co-founding Chief Executive Officer and Chief Technical Officer of Sensant Corporation, which was acquired by Siemens in 2005. Afterwards, Igal led Siemens’ Ultrasound Engineering Division. Igal has also served as advisor, angel investor, and board member at various early stage medtech companies.

Igal was educated at U.C. Berkeley, The Ecole Polytechnique, and Stanford University.

Brad Macy

Bradford Macy, RN, BSN, CHPN is a co-founder and a director of Hospi Corporation. He is a 30-year veteran hospice nurse and the inventor of the Macy Catheter.

Brad received the 2013 National Award for Hospice and Palliative Care Nurse of the Year through the National Board for Certification of Hospice and Palliative Care Nurses. He also served as President of the Bay Area chapter of the Hospice and Palliative Nurses Association.

Brad received a B.A. in psycho-physiology from California State University, Long Beach in 1987 and a B.S. in Nursing from the University of San Francisco in 1989.

Dr. Richard Popp

As a clinical cardiologist, he focused his research on developing various forms of cardiologic ultrasound. Dr. Popp is Professor of Medicine (Emeritus) at Stanford University, where he was also Senior Associate Dean for Academic Affairs from 1995-2000.

Dr. Popp continues to teach in the Stanford Biodesign Innovation Program and he served as Chair of the Conflict of Interest Committee at the Medical School. Previously, he was the Principal Medical Consultant to Hewlett Packard Laboratories and to Agilent Laboratories, as well as advisor to multiple start-up medical technology companies. Dr. Popp has served as President of the American College of Cardiology, the American Society of Echocardiography, and the Association of University Cardiologists. He is the previous Chairman of the American Board of Internal Medicine’s Cardiovascular Diseases Subspecialty Board.

Dr. Popp was also a board member for Sensant and Ardian Corporations. He is currently on the Board of Tangible Science and he is Chair of the Medical Advisory Board at Exo. Inc. Dr. Popp was also a Venture Partner at Advanced Technology Ventures and is an Advisor to Lightstone Ventures.

Tim Friedman

Tim Friedman has served as a director of Hospi Corporation since 2020. Tim is the Principal Owner of Heracles LLC, a Chicago-based private investment company founded in 2008. He is also a co-manager of a family office with a diverse portfolio of investments across multiple industries.

Tim worked as an investment banker focused on private placement transactions from 1998-2007.

He is an alum of Lehigh University (B.A. ’91), George Washington University Law School (JD ’94), and Northwestern University – Kellogg (M.B.A. ’98).

Tim is a current member of the Board of Directors of High Jump, a trustee of The Francis W. Parker School in Chicago, and a board member of the Reynolds Family Foundation.

Bob Burlinson

Robert Burlinson has served as a director of Hospi Corporation since 2019.

Bob is a Managing Partner, Co-Founder, Chief Investment Officer, and member of the Investment Committee at Regis Management Company, now part of Mercer Advisors. Bob also serves on the Skoll Foundation’s Investment Committee.

Bob previously worked as a Principal for Industrial Growth Partners, a private equity firm focused on middle-market manufacturing businesses. He also executed public and private financings and merger advisory assignments for Alex Brown & Sons, Inc. and Kidder, Peabody & Co. He began his career in the private placements group of Manufacturers Hanover Securities Corporation.

Bob received an A.B. from Stanford University and an M.B.A. from the Wharton School at the University of Pennsylvania.

Bryan Wolfe

Bryan Wolfe has served as a director of Hospi Corporation since August 2023. He has more than 20 years of experience in the post acute healthcare sector, mostly focused on home health and hospice care.

Bryan is also a member of the Post Acute Analytics Board of Directors. Previously, he co-founded Traditions Health and served in various capacities during his tenure including President/CEO and Board Member from 2008-2022. Prior to Traditions Health, Bryan served as COO and Director of Business Development for a regional home health company in Texas.

Bryan’s expertise is fueled by his convictions in the power of strong culture, ethics, and leadership excellence. Bryan enjoys volunteering as a coach for youth football and spending time with his wife and six kids. He is a graduate of Texas A&M University where he studied Agricultural Leadership & Development with an emphasis in Community Health.

Dr. Ricardo Rosenkranz

Dr. Rosenkranz has served as a director of Hospi Corporation since 2017 and Chairman of the Board since 2019.

Dr. Rosenkranz is primarily interested in the development of innovative and effective patient-centered, quality-driven health care delivery models for multiple settings and communities. For fifteen years, Dr. Rosenkranz served as a co-founder of Inovamed, S.A. de CV, a health care services provider in Mexico. Inovamed is credited with the successful financial and quality-driven turnaround of one of Mexico City’s oldest private hospitals.

Dr. Rosenkranz is Assistant Professor in Clinical Pediatrics at the Northwestern University Feinberg School of Medicine, where he has been an active participant in new curriculum development. In conjunction with the Medical Humanities and Bioethics Program at Northwestern, Dr. Rosenkranz created the nation’s first medical school curriculum for the study of magic and medicine.

Dr. Rosenkranz holds Bachelor and Master of Science Degrees from Stanford University. He obtained his Medical Degree from Cornell University Medical School in 1990 and he completed a Pediatric Residency and a Fellowship in Neonatal-Perinatal Medicine at Northwestern University in 1993 and in 1996 respectively.